Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy
These findings highlight the potential of CD34 aptamer-coupled Toc microspheres as a targeted therapy for TAO, providing a comprehensive strategy that addresses local manifestations of the disease.
Authors
- Sha Ouyang
- Jing Cao (ORCID: https://orcid.org/0000-0001-9551-5143)
- Jiayang Yin (ORCID: https://orcid.org/0009-0002-2795-8836)
- Feng Zhang (ORCID: https://orcid.org/0000-0003-3447-897X)
- Bingyu Xie (ORCID: https://orcid.org/0000-0002-7008-2043)
- Wei Xiong (ORCID: https://orcid.org/0000-0003-1635-8173)
- Yao Tan
- Juan Zhou (ORCID: https://orcid.org/0000-0002-4711-9872)
- Yong Luo
Institutions
- Central South University (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1167/iovs.66.11.57
- Citations
- 2
- Primary Topic
- Advanced biosensing and bioanalysis techniques
- Type
- article
- Field-Weighted Citation Impact
- 1.61